Cobalt MRI ICD, Cobalt XT MRI ICD, Crome MRI ICD
Medtronic Cardiac Rhythm Disease Management · Decision date Oct 29, 2026
What did the FDA decide?
The FDA record lists this 30-day notice as a supplement to P980016, the Medtronic Cardiac Rhythm Disease Management filing covering the Cobalt MRI ICD, Cobalt XT MRI ICD and Crome MRI ICD, all implantable cardioverter defibrillators (non-CRT) under product code LWS. Its supplement reason is classified as a process change involving manufacturer, sterilizer, packager or supplier; the record does not state which of those parties changed or what the change was outside the stated purpose.
The stated purpose is to adjust the rise time measurement upper limit during final functional electrical testing. This describes a change to electrical test parameters, not to the devices' clinical claims or labeled indications; the record gives no test values, no rationale for the limit, and no supporting data. Separately, the database shows no evaluation of safety or effectiveness, and the 30-day notice category is a procedural filing status rather than a finding of clinical benefit.
FDA approval order statement
to adjust rise time measurement upper limit during final functional electrical testing
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 29, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P980016/S967
- Regulatory pathway
- PMA supplement
- Product code
- LWS
- Decision code
- OK30
- Decision date
- Oct 29, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Implantable cardioverter defibrillator (non-CRT).
- Product code
- LWS
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P980016. Subsequent supplements may change the device or its indications.
FDA decision timeline
P980016 · Original PMA
VIRTUSO/ENTRUST/MAXIMO/INTRINSIC/MARQUIS/IMPLANTABLE CARDIVERTER DEFIBRILLATORS
P980016/S965 · Related supplement
Cobalt MRI ICD, Cobalt XT MRI ICD, Crome MRI ICD
P980016/S967 received
Application receipt date recorded by FDA.
P980016/S966 · Related supplement
Cobalt MRI ICD (DDPB3Dl, DDPB3D4, DVPB3Dl, DVPB3D4); Cobalt XT MRI ICD (DDPA2Dl, DDPA2D4, DVPA2Dl, DVPA2D4); Crome MRI I
P980016/S967 · FDA decision
30-Day Notice
P980016/S964 · Related supplement
Cobalt MRI ICD (DDPB3D1, DDPB3D4, DVPB3D1, DVPB3D4); Cobalt XT MRI ICD (DDPA2D1, DDPA2D4, DVPA2D1, DVPA2D4); Crome MRI I
Timeline entries are records held by MedtechLedger for P980016. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P980016
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic Cardiac Rhythm Disease Management | PMA approval | Oct 9, 1998 | FDA | |
Cobalt MRI ICD, Cobalt XT MRI ICD, Crome MRI ICDP980016/S965 | Medtronic Cardiac Rhythm Disease Management | PMA supplement | Sep 25, 2026 | FDA |
| Medtronic Cardiac Rhythm Disease Management | PMA supplement | Oct 5, 2026 | FDA | |
| Medtronic Cardiac Rhythm Disease Management | PMA supplement | Nov 4, 2026 | FDA |
Explore the linked device profile
Other records with product code LWS
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| ABBOTT MEDICAL | PMA supplement | Nov 5, 2026 | FDA | |
| Biotronik, Inc. | PMA supplement | Oct 22, 2026 | FDA | |
| Biotronik, Inc. | PMA supplement | Oct 13, 2026 | FDA | |
| Biotronik, Inc. | PMA supplement | Oct 9, 2026 | FDA | |
| BOSTON SCIENTIFIC CORPORATION | PMA supplement | Oct 2, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic Cardiac Rhythm Disease Management
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 8200 Coral Sea St. N.E, Ms Mvs11, Mounds View, MN, 55112
Sources and methodology
- Original FDA record: P980016/S967
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records





